期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | MOLECULAR MEDICINE LetPub Score 6.3
50 ratings
Rate
Reputation 7.1 Influence 5.4 Speed 6.8 | ||||||||||||||||||||||||||||
期刊簡稱 | MOL MED | ||||||||||||||||||||||||||||
ISSN | 1076-1551 | ||||||||||||||||||||||||||||
E-ISSN | 1528-3658 | ||||||||||||||||||||||||||||
h-index | 110 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 1.70%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://molmed.biomedcentral.com | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/mome | ||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||
創刊年 | 1994 | ||||||||||||||||||||||||||||
每年文章數 | 164每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 99.58% | ||||||||||||||||||||||||||||
OA Related Info![]() | APC: Yes( GBP2390; USD3190; EUR2690; ) APC waiver:Check Notes Other charges: No Keywords: disease pathogenesis、physiology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1076-1551%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[MOLECULAR MEDICINE] 的評論 | 撰寫評論 |
作者: Lei Li 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-04-01 16:45:21 評論於 This is too unfair......... ![]() ![]() |
作者: shuyang 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2025-03-23 23:19:05 評論於 The Indian editor avoided the shBh review, and after several major and minor revisions, it took five months before both reviewers accepted and recommended the current version. However, the Indian editor directly rejected the submission, citing ridiculous reasons. He was the one who requested the review in the first place and provided feedback for the revisions. It would have been better not to submit at all. Despite appealing, all communication with the editors was through one email address, and the appeal seemed to have gone nowhere. ![]() ![]() |
作者: Blue 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-18 09:18:43 評論於 Provide reviewers' opinions after two months, decide whether to directly edit or resend to the reviewers, and use the original reviewers or new ones. ![]() ![]() |
作者: 嘉兴迪迦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-16 13:39:48 評論於 Too slow. ![]() ![]() |
作者: 一个想毕业的人 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-13 14:21:55 評論於 The process is going quite smoothly. ![]() ![]() |
作者: 一个想毕业的人 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-13 14:18:08 評論於 Revision received on December 13, 2024. Submission accepted on January 8, 2025. ![]() ![]() |
作者: lemoncello 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-08 18:53:05 評論於 How is your progress going? ![]() ![]() |
作者: BDJune21 領域: 医学 審稿時間: 7.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-12-15 13:20:05 評論於 Those who were deceived into submitting articles by the 1m submission cycle on the website, who would do such a dishonest thing! I waited for 7 months!! But the final result is good, it feels like the Indian editor is too chill and can't find reviewers... Let me summarize the general submission process for reference. 5/24/13 New Submission 5/24/15 Editor Assigned-Reviewers Assigned 5/24/20&22 Under Review 6/5 Editor Assigned 7/15 Send reminder email 7/24/17 Reviewers Assigned 7/24/22 Under Review 7/24/29 Reviewers Assigned 8/1 Under Review 8/15 Reviews Completed 8/16-9/4 a total of 7 times Reviewers Assigned changes 9/9 Major Revision 11/3 Submit for revision 11/6&7 Under Review 12/6 Send reminder email 12/9 Accept ![]() ![]() |
作者: Oracion 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-12-04 23:41:09 評論於 Submission process (for reference): Submitted in July, found reviewers in September, revised in October, resubmitted after one month, accepted on December 1st based on the opinion of only one reviewer. The direction is pharmacology with experimental verification, which has many journals for submission and a high acceptance rate. ![]() ![]() |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-30 22:59:25 評論於 How is it going now? Is there any result yet? ![]() ![]() |
作者: lemoncello 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-03 23:21:54 評論於 Has the external audit finished? ![]() ![]() |
作者: Edgar Young 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-30 17:24:13 評論於 Recently found that this magazine is too slow, the reviewers generally take about 2 weeks to reply. ![]() ![]() |
作者: shanzhenxieqi 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-10-28 11:46:42 評論於 A world-class journal, with the only drawback being a slightly slower review process. The feedback from the reviewers for the review article I submitted was very insightful, and the revisions were straightforward, leading to direct acceptance. The submission system is also very well-designed, much better than the outdated systems used by most journals, and there is no word limit. I am grateful that a certain CS journal rejected me, as it led me to this journal which is 1.5 points higher in quality. I love BMC. ![]() ![]() |
作者: Atwood Churchill 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-18 21:15:49 評論於 Waiting for a follow-up. ![]() ![]() |
作者: 香菜1 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-11 20:11:59 評論於 I am not sure if I should submit now. I have another article that I have already submitted, but it is taking a long time. I am undecided whether to withdraw it and see if there are other magazines to submit to. ![]() ![]() |
作者: wfegfg 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-11 09:41:20 評論於 Is this a scam? How long has the external audit been going on for? ![]() ![]() |
作者: wfegfg 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-11 09:40:05 評論於 It's been over two months since the review, no news yet. How can we say the average review time is 1 month? Not sure what's going on, eagerly awaiting the results. ![]() ![]() |
作者: lemoncello 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-04 21:41:22 評論於 Has the external audit come back yet? ![]() ![]() |
作者: 大雨不治水 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-04 21:37:57 評論於 How often does everyone send for external review? ![]() ![]() |
作者: 一个想毕业的人 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-08 08:27:49 評論於 8.8 同行评审 Peer review ![]() ![]() |
作者: 一个想毕业的人 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-07 14:10:03 評論於 Already invested for 1 week. ![]() ![]() |
作者: 是你的思萌呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-10 11:53:48 評論於 Gutenberg is so slow, the article I submitted in March last year is still under review. ![]() ![]() |
作者: moonriver120 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 07:43:02 評論於 Hi, I would like to ask the host, what are the quick and smooth steps you take to submit contributions? Are there any tips or key points to keep in mind when writing a cover letter or other letters to ensure that the editor or reviewer is willing to quickly and seamlessly connect step by step? Please advise. ![]() ![]() |
作者: qingqing 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-22 02:00:05 評論於 What does this mean, going straight into peer review? ![]() ![]() |
作者: zhongzhong123 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-16 11:33:37 評論於 The retraction notice was sent through the system in the morning, and the paper was retracted in the afternoon ![]() ![]() |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us